Cd4 T Cell Epitopes | List of Frontiers open access articles

Original Research

Published on 05 May 2017

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors

in Vaccines and Molecular Therapeutics

Moustafa Hamze
Sylvain Meunier
Anette Karle
Abdelaziz Gdoura
Amélie Goudet
Natacha Szely
Marc Pallardy
Franck Carbonnel
Sebastian Spindeldreher
Xavier Mariette

Frontiers in Immunology

doi 10.3389/fimmu.2017.00500

14,529 views
81 citations

Original Research

Published on 30 May 2018

Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection

in Vaccines and Molecular Therapeutics

Maximilian Koblischke
Karin Stiasny
Stephan W. Aberle
Stefan Malafa
Georgios Tsouchnikas
Julia Schwaiger
Michael Kundi
Franz X. Heinz
Judith H. Aberle

Frontiers in Immunology

doi 10.3389/fimmu.2018.01196

5,464 views
33 citations

Original Research

Published on 13 Sep 2022

HLAII peptide presentation of infliximab increases when complexed with TNF

in Vaccines and Molecular Therapeutics

Andrea Casasola-LaMacchia
Robert Joseph Seward
Sophie Tourdot
Matthew Willetts
Gary Kruppa
Michael J. Agostino
Gabrielle Bergeron
Nathalie Ahyi-Amendah
Andrew Ciarla
Zhaojiang Lu

Frontiers in Immunology

doi 10.3389/fimmu.2022.932252

6,392 views
10 citations

Correction

Published on 11 Sep 2018

Corrigendum: Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection

in Vaccines and Molecular Therapeutics

Maximilian Koblischke
Karin Stiasny
Stephan W. Aberle
Stefan Malafa
Georgios Tsouchnikas
Julia Schwaiger
Michael Kundi
Franz X. Heinz
Judith H. Aberle

Frontiers in Immunology

doi 10.3389/fimmu.2018.02083

2,018 views
6 citations

Original Research

Published on 28 Jul 2023

Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity

in Antigen Presenting Cell Biology

Coline Sivelle
Raphael Sierocki
Youen Lesparre
Aurore Lomet
Wagner Quintilio
Steven Dubois
Evelyne Correia
Ana Maria Moro
Bernard Maillère
Hervé Nozach

Frontiers in Immunology

doi 10.3389/fimmu.2023.1197919

5,131 views
7 citations

Original Research

Published on 08 Jun 2021

Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains

in Vaccines and Molecular Therapeutics

Amy R. Noe
Frances E. Terry
Brian C. Schanen
Emily Sassano
Pooja Hindocha
Timothy W. Phares
Leonard Moise
Jayne M. Christen
Kenneth D. Tucker
Vinayaka Kotraiah

Frontiers in Immunology

doi 10.3389/fimmu.2021.689920

5,297 views
4 citations

Original Research

Published on 06 Mar 2024

The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes

in Immunological Tolerance and Regulation

Valeria Porcheddu
Gautier Lhomme
Rémi Giraudet
Evelyne Correia
Bernard Maillère

Frontiers in Immunology

doi 10.3389/fimmu.2024.1345195

3,520 views
7 citations

Original Research

Published on 05 Dec 2022

High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells

in Viral Immunology

Chansavath Phetsouphanh
Weng Hua Khoo
Katherine Jackson
Vera Klemm
Annett Howe
Anupriya Aggarwal
Anouschka Akerman
Vanessa Milogiannakis
Alberto Ospina Stella
Romain Rouet

Frontiers in Immunology

doi 10.3389/fimmu.2022.1032911

7,404 views
17 citations

Methods

Published on 17 Aug 2021

PopCover-2.0. Improved Selection of Peptide Sets With Optimal HLA and Pathogen Diversity Coverage

in Vaccines and Molecular Therapeutics

Jonas Birkelund Nilsson
Alba Grifoni
Alison Tarke
Alessandro Sette
Morten Nielsen

Frontiers in Immunology

doi 10.3389/fimmu.2021.728936

6,830 views
11 citations

Original Research

Published on 05 Jul 2019

Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses

in Viral Immunology

Alba Grifoni
Eugene Moore
Hannah Voic
John Sidney
Elizabeth Phillips
Ramesh Jadi
Simon Mallal
Aruna D. De Silva
Aravinda M. De Silva
Bjoern Peters

Frontiers in Immunology

doi 10.3389/fimmu.2019.01568

8,831 views
43 citations

Original Research

Published on 13 Feb 2019

Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in Mycobacterium tuberculosis Strains

in Microbial Immunology

Arunachalam Ramaiah
Soumya Nayak
Srabanti Rakshit
Abigail L. Manson
Thomas Abeel
Sivakumar Shanmugam
Pravat Nalini Sahoo
Anto Jesuraj Uday Kumar John
Jagadish Chandrabose Sundaramurthi
Sujatha Narayanan

Frontiers in Immunology

doi 10.3389/fimmu.2019.00195

8,264 views
9 citations

Original Research

Published on 16 Oct 2020

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines

in Vaccines and Molecular Therapeutics

Pedro A. Reche

Frontiers in Immunology

doi 10.3389/fimmu.2020.586984

85,788 views
108 citations

Articles

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors

Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection

HLAII peptide presentation of infliximab increases when complexed with TNF

Corrigendum: Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection

Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity

Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains

The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes

High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells

PopCover-2.0. Improved Selection of Peptide Sets With Optimal HLA and Pathogen Diversity Coverage

Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses

Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in Mycobacterium tuberculosis Strains

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines